98 related articles for article (PubMed ID: 9717957)
1. Surveillance of antifolate-resistant malaria.
Basco LK; Tahar R; Ringwald P
Lancet; 1998 Aug; 352(9125):406. PubMed ID: 9717957
[No Abstract] [Full Text] [Related]
2. Molecular assays for surveillance of antifolate-resistant malaria.
Kublin JG; Witzig RS; Shankar AH; Zurita JQ; Gilman RH; Guarda JA; Cortese JF; Plowe CV
Lancet; 1998 May; 351(9116):1629-30. PubMed ID: 9620719
[No Abstract] [Full Text] [Related]
3. More on 'the efficacy of antifolate antimalarial combinations in Africa'.
Watkins WM; Mberu EK; Winstanley PA; Plowe CV
Parasitol Today; 1999 Apr; 15(4):131-2. PubMed ID: 10322331
[No Abstract] [Full Text] [Related]
4. Selection and synergy in Plasmodium falciparum.
Sims P; Wang P; Hyde JE
Parasitol Today; 1999 Apr; 15(4):132-4. PubMed ID: 10322332
[No Abstract] [Full Text] [Related]
5. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
Plowe CV; Cortese JF; Djimde A; Nwanyanwu OC; Watkins WM; Winstanley PA; Estrada-Franco JG; Mollinedo RE; Avila JC; Cespedes JL; Carter D; Doumbo OK
J Infect Dis; 1997 Dec; 176(6):1590-6. PubMed ID: 9395372
[TBL] [Abstract][Full Text] [Related]
6. Malaria cure with sulphadoxine/pyrimethamine combination in 12 semi-immune adults from West-Central Africa with high rates of point mutations in Plasmodium falciparum dhfr and dhps genes.
Berzosa PJ; Puente S; Benito A
Parasitol Res; 2005 Oct; 97(4):287-9. PubMed ID: 16012864
[TBL] [Abstract][Full Text] [Related]
7. Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains.
Kun JF; Lehman LG; Lell B; Schmidt-Ott R; Kremsner PG
Antimicrob Agents Chemother; 1999 Sep; 43(9):2205-8. PubMed ID: 10471565
[TBL] [Abstract][Full Text] [Related]
8. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins.
Wang P; Lee CS; Bayoumi R; Djimde A; Doumbo O; Swedberg G; Dao LD; Mshinda H; Tanner M; Watkins WM; Sims PF; Hyde JE
Mol Biochem Parasitol; 1997 Nov; 89(2):161-77. PubMed ID: 9364963
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
10. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424
[TBL] [Abstract][Full Text] [Related]
11. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
Biswas S
J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
[TBL] [Abstract][Full Text] [Related]
12. Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?
Nzila A; Ochong E; Nduati E; Gilbert K; Winstanley P; Ward S; Marsh K
Trans R Soc Trop Med Hyg; 2005 May; 99(5):341-6. PubMed ID: 15780340
[TBL] [Abstract][Full Text] [Related]
13. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
Djaman AJ; Basco LK; Mazabraud A
Sante; 2002; 12(4):363-7. PubMed ID: 12626289
[TBL] [Abstract][Full Text] [Related]
14. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
[TBL] [Abstract][Full Text] [Related]
15. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
[TBL] [Abstract][Full Text] [Related]
17. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new sulfadoxine sensitivity assay in vitro for field isolates of Plasmodium falciparum.
Ndounga M; Basco LK; Ringwald P
Trans R Soc Trop Med Hyg; 2001; 95(1):55-7. PubMed ID: 11280067
[No Abstract] [Full Text] [Related]
19. Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
Tessema SK; Kassa M; Kebede A; Mohammed H; Leta GT; Woyessa A; Guma GT; Petros B
PLoS One; 2015; 10(10):e0126943. PubMed ID: 26431464
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine.
Zakeri S; Farahani MS; Afsharpad M; Salehi M; Raeisi A; Djadid ND
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e123-8. PubMed ID: 20399698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
